SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 162 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2016. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $9,493,000 | -70.5% | 3,273,509 | -54.7% | 1.85% | -67.9% |
Q2 2017 | $32,145,000 | -4.5% | 7,223,509 | 0.0% | 5.76% | -13.9% |
Q1 2017 | $33,662,000 | +11.1% | 7,223,509 | +45.2% | 6.68% | +7.4% |
Q4 2016 | $30,289,000 | -14.4% | 4,973,509 | -22.6% | 6.22% | -31.0% |
Q3 2016 | $35,386,000 | +22.7% | 6,422,232 | -15.4% | 9.02% | +9.3% |
Q2 2016 | $28,842,000 | +380.5% | 7,590,000 | +249.0% | 8.26% | +283.4% |
Q1 2016 | $6,003,000 | -31.6% | 2,175,000 | +40.6% | 2.15% | -41.5% |
Q4 2015 | $8,771,000 | +45.7% | 1,546,888 | +36.2% | 3.68% | +54.6% |
Q3 2015 | $6,019,000 | -63.9% | 1,135,580 | -43.5% | 2.38% | -63.4% |
Q2 2015 | $16,683,000 | – | 2,009,984 | – | 6.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,273,509 | $9,493,000 | 1.85% |
Trellus Management Company, LLC | 362,500 | $1,051,000 | 1.44% |
Paulson & Co. | 24,062,368 | $69,781,000 | 1.25% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 971,922 | $2,799,000 | 1.09% |
Asymmetry Capital Management, L.P. | 271,102 | $786,000 | 0.91% |
Cheyne Capital Management (UK) LLP | 651,500 | $1,880,000 | 0.68% |
Hikari Power Ltd | 1,500,000 | $4,350,000 | 0.56% |
Orbimed Advisors | 13,621,443 | $39,502,000 | 0.38% |
CARL DOMINO INC | 83,000 | $241,000 | 0.29% |
KNOTT DAVID M | 158,400 | $459,000 | 0.20% |